Related Experiment Video
Updated: Aug 14, 2026

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
Published on: August 2, 2016
Preparation and characterization of dehydration-rehydration vesicles loaded with aminoglycoside and macrolide
Clement Mugabe1, Ali O Azghani, Abdelwahab Omri
1The Novel Drug & Vaccine Delivery Systems Facility, Department of Chemistry and Biochemistry, Laurentian University, Sudbury, Ont., Canada P3E 2C6.
Abstract:
Enhanced activity of liposomes-encapsulated antibiotics against clinical isolates of Pseudomonas aeruginosa has been documented with liposomes of low encapsulation efficiency. We sought to construct liposomes with high yield entrapment of aminoglycoside and macrolide antibiotics as well as favorable stability in storage and physiological conditions. Liposome-entrapped aminoglycosides (amikacin, gentamicin, tobramycin) and a macrolide (erythromycin) were prepared by a modified dehydration-rehydration vesicles (DRVs) method, and their particle size and entrapment efficiency were determined. We studied in vitro stability of these vesicles over a 48 h period at 4 and 37 degrees C in phosphate-buffered saline (PBS) and in plasma at 37 degrees C. The mean particle size of DRVs loaded with antibiotics varied from 163.37+/-38.44 to 259.83+/-11.80 nm with no significant difference in regard with the type of the antibiotics encapsulated. Encapsulation efficiency of DRVs loaded with amikacin, gentamicin, tobramycin, and erythromycin were 29.27+/-1.17, 33+/-0.76, 22.33+/-1.48 and 32.06+/-0.82% of initial amount of the drug, respectively. These vesicles were stable regardless of the experimental temperature. Indeed, the liposomes retained more than 75% of the initially encapsulated drugs for the study period of 48 h. DRVs incubated in plasma however, released more antibiotics than those incubated in PBS. In conclusion, using this modified DRV method, we obtained small sized vesicles with high yield entrapment for aminoglycoside and macrolide antibiotics. The technique may be utilized to overcome the low encapsulation efficiency associated with aminoglycoside and macrolide antibiotics.
Insights
This study developed liposomes with high encapsulation efficiency for antibiotics like amikacin and erythromycin. The modified dehydration-rehydration vesicles (DRVs) method improves drug delivery for challenging bacterial infections.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery Systems
- Microbiology
Background:
- Liposomes show enhanced activity against Pseudomonas aeruginosa, but low encapsulation efficiency is a limitation.
- Aminoglycoside and macrolide antibiotics are crucial for treating bacterial infections.
- Improving liposome encapsulation efficiency is key to enhancing antibiotic efficacy.
Purpose of the Study:
- To develop liposomes with high entrapment yield for aminoglycoside and macrolide antibiotics.
- To assess the stability of these liposomes under storage and physiological conditions.
- To overcome the challenge of low encapsulation efficiency in antibiotic liposomes.
Main Methods:
- Modified dehydration-rehydration vesicles (DRVs) method used for liposome preparation.
- Encapsulation efficiency and particle size of liposome-entrapped antibiotics determined.
- In vitro stability assessed over 48 hours in phosphate-buffered saline (PBS) and plasma at varying temperatures.
Main Results:
- Liposome-entrapped aminoglycosides (amikacin, gentamicin, tobramycin) and erythromycin showed encapsulation efficiencies ranging from 22.33% to 33%.
- Mean particle size of the vesicles ranged from 163.37 to 259.83 nm.
- Liposomes retained over 75% of encapsulated drugs for 48 hours, demonstrating good stability, though plasma led to higher drug release than PBS.
Conclusions:
- The modified DRVs method successfully produced small-sized liposomes with high yield entrapment for aminoglycoside and macrolide antibiotics.
- This technique offers a potential solution to the low encapsulation efficiency issue associated with these antibiotic classes.
- The developed liposomes show promise for improved antibiotic delivery and efficacy.
